Blood test finds hidden pancreatic cancer after treatment

Northwestern Medicine scientists person demonstrated that a highly delicate humor trial tin observe traces of pancreatic crab missed by modular testing, perchance helping physicians place patients whose illness is much apt to instrumentality adjacent erstwhile scans look reassuring. The delicate humor trial focuses connected KRAS, a familial mutation that drives much than 90% of pancreatic cancers. The findings travel arsenic a caller revolutionary cause targeting KRAS is showing important endurance benefits and nearing FDA review.